For example, breast and colorectal cancer progression was attributed to obesity [16], and in liver and gallbladder cancers, 51% of the cases are caused by this overweight disease [16]
This content is part of EMARKETERs subscription Briefings, where we pair daily updates with data and analysis from forecasts and research reports
The Effect of Berberine Supplementation on Obesity Parameters, Inflammation and Liver Function Enzymes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
How many people are using GLP-1 medications By the numbers: According to the poll, the share of U.S
TL;DR GLP-1 microdosing involves taking significantly lower doses of medications like semaglutide (0.05-0.25mg weekly) compared to standard therapeutic doses (0.25-2.4mg)
Novo Nordisk received FDA approval for the Wegovy pill, the first and only oral GLP-1 on the market thats FDA-approved for weight management